Jun Jiang

3.8k citations

113 papers · 2.0k indexed · h-index 25

Impact in

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
Molecular Biology top 10%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Metabolism, Diabetes, and Cancer

Papers in ⓘ

Molecular Biology 53
- RNA modifications and cancer 9
- Epigenetics and DNA Methylation 9
- Metabolism, Diabetes, and Cancer 6
Pulmonary and Respiratory Medicine 36
- Prostate Cancer Treatment and Research 14
- Renal cell carcinoma treatment 7

Co-authors: Dianzheng Zhang (31 shared papers)Qiuli Liu (33 shared papers)Dali Tong (23 shared papers)Weihua Lan (24 shared papers)Gaolei Liu (20 shared papers)Jing Xu (16 shared papers)Luofu Wang (21 shared papers)Hualiang Xiao (5 shared papers)
Journals: Medicine (4 papers)Frontiers in Oncology (4 papers)Journal of Cancer (4 papers)Endocrine Connections (3 papers)Cancer Biology & Therapy (3 papers)
Partner nations: China United States South Korea

In The Last Decade

Jun Jiang

105 papers receiving 1.9k citations

Peers

Countries citing papers authored by Jun Jiang

Since Specialization

Citations

This map shows the geographic impact of Jun Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Jiang more than expected).

Fields of papers citing papers by Jun Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Jiang. The network helps show where Jun Jiang may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun Jiang Line = papers co-authored together Jun Jiang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Lactate Modulates Cellular Metabolism Through Histone Lactylation-Mediated Gene Expression in Non-Small Cell Lung Cancer Frontiers in Oncology ·Jun Jiang, Dengliang Huang, Yuan Jiang, Jing Hou, Meiyuan Tian, Jianhua Li, Li Sun, Yaogang Zhang, Tao Zhang, ZhiQin Li, Zhongcheng Li, SiXian Tong, Yanyan Ma	2021	186
2	Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis Cancer Letters ·Dali Tong, Qiuli Liu, Gaolei Liu, Jing Xu, Weihua Lan, Yao Jiang, Hualiang Xiao, Dianzheng Zhang, Jun Jiang	2016	106
3	Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT Cell Death and Disease ·Qiuli Liu, Dali Tong, Gaolei Liu, Jing Xu, Khang Do, Kyla Geary, Dianzheng Zhang, Jun Zhang, Yao Zhang, Yaoming Li, Gang Bi, Weihua Lan, Jun Jiang	2017	88
4	Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration Clinical Cancer Research ·Qiuli Liu, Dali Tong, Gaolei Liu, Jie Gao, Lin-ang Wang, Jing Xu, Xingxia Yang, Qiubo Xie, Yiqiang Huang, Jian Pang, Luofu Wang, Yong He, Dianzheng Zhang, Qiang Ma, Weihua Lan, Jun Jiang	2018	86
5	The roles of the COX2/PGE2/EP axis in therapeutic resistance Cancer and Metastasis Reviews ·Dali Tong, Qiuli Liu, Lin-ang Wang, Qiubo Xie, Jian Pang, Yiqiang Huang, Luofu Wang, Gaolei Liu, Dianzheng Zhang, Weihua Lan, Jun Jiang	2018	84
6	AOF1 is a histone H3K4 demethylase possessing demethylase activity-independent repression function Cell Research ·Ze Yang, Jun Jiang, M. Stewart, Shankang Qi, Kenichi Yamane, Jiwen Li, Yi Zhang, Jiemin Wong	2010	58
7	Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis Oncotarget ·Qiuli Liu, Wenqiang Yuan, Dali Tong, Gaolei Liu, Weihua Lan, Dianzheng Zhang, Hualiang Xiao, Yao Zhang, Zaoming Huang, Junjie Yang, Jun Zhang, Jun Jiang	2016	58
8	Metformin represses androgen‐dependent and androgen‐independent prostate cancers by targeting androgen receptor The Prostate ·Yan Wang, Gaolei Liu, Dali Tong, Henna Parmar, Donald Hasenmayer, Wenqiang Yuan, Dianzheng Zhang, Jun Jiang	2015	51
9	The HIF/PHF8/AR axis promotes prostate cancer progression Oncogenesis ·Dali Tong, Q Liu, G Liu, Weishan Yuan, L Wang, Yanli Guo, Weihua Lan, D Zhang, Suwei Dong, Y Wang, Hualiang Xiao, JIANG-HONG MU, Chenzhou Mao, Jiemin Wong, Jun Jiang	2016	49
10	Dissecting copper biology and cancer treatment: ‘Activating Cuproptosis or suppressing Cuproplasia’ Coordination Chemistry Reviews ·Ying Yang, Man Li, Gang Chen, Suyi Liu, Houqi Guo, Xiongwei Dong, Kai Wang, Hongen Geng, Jun Jiang, Xiang Li	2023	49
11	Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2 The Journal of Pathology ·Qiuli Liu, Jian Pang, Lin‐ang Wang, Zhuowei Huang, Jing Xu, Xingxia Yang, Qiubo Xie, Yiqiang Huang, Tang Tang, Dali Tong, Gaolei Liu, Luofu Wang, Dianzheng Zhang, Qiang Ma, Hualiang Xiao, Weihua Lan, Jun Qin, Jun Jiang	2020	48
12	Proteomics revealed the crosstalk between copper stress and cuproptosis, and explored the feasibility of curcumin as anticancer copper ionophore Free Radical Biology and Medicine ·Ying Yang, (unknown), Hongen Geng, Mengmeng Xiong, Man Li, Qian Su, Fang Jia, Yimei Zhao, Kai Wang, Jun Jiang, Si Qin, Xiang Li	2022	46
13	MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K/Akt pathway Journal of Experimental & Clinical Cancer Research ·Jun Jiang, Yitong Xu, Hongjiu Ren, Muli Wudu, Qiongzi Wang, Xin Song, Hongbo Su, Xizi Jiang, Lihong Jiang, Xueshan Qiu	2018	39
14	Liddle syndrome: clinical and genetic profiles Journal of Clinical Hypertension ·Yunying Cui, Anli Tong, Jun Jiang, Fen Wang, Chunyan Li	2016	37
15	Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer Journal for ImmunoTherapy of Cancer ·Liangliang Cai, Hua Bai, Jianchun Duan, Zhijie Wang, Shugeng Gao, Di Wang, Shuhang Wang, Jun Jiang, Jiefei Han, Yanhua Tian, Xue Zhang, Hao Ye, Minghui Li, Bingding Huang, Jie He, Jie Wang	2019	36
16	Detection of human enterovirus 71 and Coxsackievirus A16 in an outbreak of hand, foot, and mouth disease in Henan Province, China in 2009 Virus Genes ·Xingliang Fan, Jun Jiang, Yanjing Liu, Xueyong Huang, Pengzhi Wang, Licheng Liu, Junzhi Wang, Weijun Chen, Weili Wu, Bianli Xu	2012	34
17	A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression Oncogene ·Cunjie Chang, Jianghuai Liu, Wei He, Mingxuan Qu, Xiaojing Huang, Yuan-Rui Deng, Lan Shen, Xiaozhi Zhao, Hongqian Guo, Jun Jiang, Xiao Fu, Ruimin Huang, D Zhang, Jun Yan	2017	34
18	LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT Frontiers in Oncology ·Qiubo Xie, Tang Tang, Jian Pang, Jing Xu, Xingxia Yang, Lin-ang Wang, Yiqiang Huang, Zhuowei Huang, Gaolei Liu, Dali Tong, Yao Zhang, Luofu Wang, Dianzheng Zhang, Weihua Lan, Qiuli Liu, Jun Jiang	2020	34
19	Knockdown of lncRNA MIR503HG suppresses proliferation and promotes apoptosis of non-small cell lung cancer cells by regulating miR-489-3p and miR-625-5p Pathology - Research and Practice ·Runa Dao, Muli Wudu, Linping Hui, Jun Jiang, Yitong Xu, Hongjiu Ren, Xueshan Qiu	2020	33
20	The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma Frontiers in Endocrinology ·Peng Song, Jun Zhang, Xintao Tan, Yiqiang Huang, Jing Xu, Natalie Silk, Dianzheng Zhang, Qiuli Liu, Jun Jiang	2020	33

About Jun Jiang

Jun Jiang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Cancer Research, having authored 113 papers that have together received 2.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (14 papers), Cancer, Hypoxia, and Metabolism (13 papers), RNA modifications and cancer (9 papers), Epigenetics and DNA Methylation (9 papers), Adrenal and Paraganglionic Tumors (8 papers), Renal cell carcinoma treatment (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Cancer Research (590 citations), Molecular Biology (1.1k citations), Oncology (429 citations), Pulmonary and Respiratory Medicine (382 citations) and Endocrinology, Diabetes and Metabolism (152 citations). Jun Jiang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Dianzheng Zhang, Qiuli Liu, Dali Tong, Weihua Lan, Gaolei Liu, Jing Xu, Luofu Wang, Hualiang Xiao, Yiqiang Huang and Lin-ang Wang. Their work appears in journals such as Medicine, Frontiers in Oncology, Journal of Cancer, Endocrine Connections and Cancer Biology & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact